TrialBlood cancer journal2017

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment.

M A Dimopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.